Visual Analogue Scale to score the effects of Botulinum Toxin A treatment in children with cerebral palsy in daily clinical practice

European Journal of Paediatric Neurology

Volumn 12, Issue 3, 2008, Pages 231-238

  Vles, Georges F ^a   de Louw, Anton J A ^b   Speth, Lucianne A ^c   van Rhijn, Lodewijk W ^a   Janssen Potten, Yvonne J M ^a,c   Hendriksen, Jos G ^b   Vles, Johan S H ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b EPILEPSY CENTER KEMPENHAEGHE   (Netherlands)

^c Child Rehab Center Franciscusoord   (Netherlands)

Author keywords

Botulinum Toxine A; Cerebral palsy; Visual Analogue Scale

Indexed keywords

BOTULINUM TOXIN A;

ADOLESCENT; ADULT; ARTICLE; CAREGIVER; CEREBRAL PALSY; CHILD; CLINICAL PRACTICE; CONSTIPATION; CONSULTATION; CORRELATION ANALYSIS; DEVICE; DIARRHEA; DISEASE EXACERBATION; DRUG EFFICACY; FEMALE; FLU LIKE SYNDROME; HUMAN; MAJOR CLINICAL STUDY; MALE; NURSING; OUTPATIENT CARE; PRIORITY JOURNAL; RELIABILITY; SITTING; SPASTICITY; STANDING; STATISTICAL SIGNIFICANCE; VISUAL ANALOG SCALE; WALKING;

ADOLESCENT; BOTULINUM TOXIN TYPE A; CEREBRAL PALSY; CHILD; FEMALE; HUMANS; MALE; MUSCLE SPASTICITY; NEUROMUSCULAR AGENTS; PAIN; PAIN MEASUREMENT; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME; WALKING;

EID: 42249105862     PISSN: 10903798     EISSN: 15322130     Source Type: Journal    
DOI: 10.1016/j.ejpn.2007.08.002     Document Type: Article

References (35)

1. Krigger K.W. Cerebral palsy an overview. Am Fam Physician 73 1 (2006) 91-100
2. Lance J.W. Disordered muscle tone and movement. Clin Exp Neurol 18 (1981) 27-35
3. Koman L.A., Mooney J.F., Smith B.P., Walker F., and Leon J.M. Botulinum toxin type A neuromuscular blockade in the treatment of lower extremity spasticity in cerebral palsy: a randomized, double-blind, placebo-controlled trial. J Pediatr Orthop 20 1 (2000) 108-115
4. Wissel J., Muller J., Dressnandt J., et al. Management of spasticity associated pain with botulinum toxin A. J Pain Symptom Manage 20 1 (2000) 44-49
5. Mall V., Heinen F., Siebel A., et al. Treatment of adductor spasticity with BTX-A in children with CP: a randomized, double-blind, placebo-controlled study. Dev Med Child Neurol 48 1 (2006) 10-13
6. Symons F.J., Rivard P.F., Nugent A.C., and Tervo R.C. Parent evaluation of spasticity treatment in cerebral palsy using botulinum toxin type A. Arch Phys Med Rehabil 87 12 (2006) 1658-1660
7. Koman L.A., Mooney III J.F., Smith B.P., Goodman A., and Mulvaney T. Management of cerebral palsy with botulinum-A toxin: preliminary investigation. J Pediatr Orthop 13 4 (1993) 489-495
8. Cosgrove A.P., Corry I.S., and Graham H.K. Botulinum toxin in the management of the lower limb in cerebral palsy. Dev Med Child Neurol 36 5 (1994) 386-396
9. Denislic M., and Meh D. Botulinum toxin in the treatment of cerebral palsy. Neuropediatrics 26 5 (1995) 249-252
10. Levin M.F. On the nature and measurement of spasticity. Clin Neurophysiol 116 8 (2005) 1754-1755
11. Damiano D.L., Quinlivan J.M., Owen B.F., et al. What does the Ashworth scale really measure and are instrumented measures more valid and precise?. Dev Med Child Neurol 44 2 (2002) 112-118
12. Biering-Sorensen F., Nielsen J.B., and Klinge K. Spasticity-assessment: a review. Spinal Cord 44 12 (2006) 708-722
13. Scholtes V.A.B., Becher J.G., Beelen A., and Lankhorst G.J. Clinical assessment of spasticity in children with cerebral palsy: a critical review of available instruments. Dev Med Child Neurol 48 (2006) 64-73
14. Mall V., Heinen F., Kirschner J., et al. Evaluation of botulinum toxin A therapy in children with adductor spasm by gross motor function measure. J Child Neurol 15 4 (2000) 214-217
15. Stinson J.N., Kavanagh T., Yamada J., Gill N., and Stevens B. Systematic review of the psychometric properties, interpretability and feasibility of self-report pain intensity measures for use in clinical trials in children and adolescents. Pain 125 1-2 (2006) 143-157
16. Ade-Hall R.A., and Moore A.P. Botulinum toxin type A in the treatment of lower limb spasticity in cerebral palsy. Cochrane Database Syst Rev 2 (2000) CD001408
17. Love S.C., Valentine J.P., Blair E.M., Price C.J., Cole J.H., and Chauvel P.J. The effect of botulinum toxin type A on the functional ability of the child with spastic hemiplegia: a randomized controlled trial. Eur J Neurol 8 Suppl. 5 (2001) 50-58
18. Reddihough D.S., King J.A., Coleman G.J., Fosang A., McCoy A.T., and Thomassen P. Functional outcome of botulinum toxin A injections to the lower limb in cerebral plasy. Dev Med Child Neurol 44 (2002) 820-827
19. Shakespeare D.T., Boggild M., and Young C. Anti-spasticity agents for multiple sclerosis. Cochrane Database Syst Rev 4 (2003)
20. Gregson J.M., Leatlhey M., Moore A.P., et al. Reliability of the Tone Assessment Scale and the Modified Ashworth Scale as clinical tools for assessing poststroke spasticity. Arch Phys Med Rehabil 80 9 (1999) 1013-1016
21. Fosang A.L., Galea M.P., McCoy A.T., Reddihough D.S., and Story I. Measures of muscle and joint performance in the lower limb of children with cerebral palsy. Dev Med Child Neurol 45 10 (2003) 664-670
22. Kilgour G., McNair P., and Scott N.S. Interrater reliability of lower limb sagittal range-of-motion measures in children witch spastic diplegia. Dev Med Child Neurol 45 (2003) 391-399
23. Guyatt G., Townsend M., Bernard B., and Keller K.L. A comparison of Likert and visual analogue scales for measuring change in function. J Chronic Dis 40 (1987) 1129-1133
24. Aitken R.C. Measurement of feelings using visual analogue scales. Proc R Soc Med 62 10 (1969) 989-993
25. Jaeschke R., Singer J., and Guyatt G. A comparison of seven point and visual analogue scales. Control Clin Trials 11 (1990) 43-51
26. Singer A.J., and Thode H.C. Determination of the minimal clinically significant difference on a patient visual analog satisfaction scale. Acad Emerg Med 5 10 (1998) 1007-1011
27. Sherman S.A., Eisen S., Burwinkle T.M., and Varni J.W. The PedsQL Present Functioning Visual Analogue Scales: preliminary reliability and validity. Health Qual Life Outcomes 4 (2006) 75
28. Hunt O., Burden D., Hepper P., Stevenson M., and Johnston C. Parent reports of the psychosocial functioning of children with cleft and/or palate. Cleft Palate Craniofac J 44 3 (2007) 304-311
29. Iyer L.V., Haley S.M., Watkins M.P., and Dumas H.M. Establishing minimal clinically important differences for scores on the pediatric evaluation of disability inventory for inpatient rehabilitation. Phys Ther 83 10 (2003) 888-898
30. Hanna K., and Rodger S. Towards family-centered practice in paediatric occupational therapy: a review of the literature on parent-therapist collaboration. Aust Occup Ther J 49 (2002) 4-24
31. White-Koning M., Arnaud C., Bourdet-Loubere S., et al. Subjective quality of life in children with intellectual impairment-how can it be assessed?. Dev Med Child Neurol 47 4 (2005) 281-285
32. Sköld C. Spasticity in spinal cord injury: self- and clinically rated intrinsic fluctuations and intervention-induced changes. Arch Phys Med Rehabil 81 2 (2000) 144-149
33. Kiresuk T.J., and Sherman R.E. Goal attaining scaling: a general method for evaluating community mental health programs. Community Ment Health J 4 (1968) 442-453
34. Cusick A., McIntyre S., Novak I., et al. A comparison of goal attainment scaling and the Canadian occupational performance for paediatric rehabilitation research. Pediatr Rehabil 9 2 (2006) 149-157
35. Duco Steenbeek. Goal attainment scaling in paediatric rehabilitation: a critical review of the literature. Dev Med Child Neurol 49 (2007) 550-556